Pancreatic Ductal Carcinoma: Slow Progress for a Hard-to-Treat Cancer

Newsfeed Image, Light Gray Text On Dark Gray Background
The incidence of pancreas cancer continues to rise in many countries. In 2017, an estimated 53,600 cases were diagnosed in the United States, representing an approximately 45% increase over the past decade. Pancreatic ductal adenocarcinoma (PDAC), which is considered incurable, accounts for more than 90% of pancreatic cancer cases.   

Amid this backdrop, a panel of experts from North America and Europe discussed emerging issues in the treatment of PDAC during an OncLive Peer Exchange® program Read more . . .

image_printPrint Page